Feldstein AE - Search Results

1

Novel therapeutic targets for nonalcoholic fatty liver disease.

Eguchi A, Povero D, Alkhouri N, Feldstein AE. Eguchi A, et al. Among authors: feldstein ae. Expert Opin Ther Targets. 2013 Jul;17(7):773-9. doi: 10.1517/14728222.2013.789502. Epub 2013 Apr 22. Expert Opin Ther Targets. 2013. PMID: 23600493 Review.

2

Apoptosis in alcoholic and nonalcoholic steatohepatitis.

Feldstein AE, Gores GJ. Feldstein AE, et al. Front Biosci. 2005 Sep 1;10:3093-9. doi: 10.2741/1765. Front Biosci. 2005. PMID: 15970563 Review.

3

Nonalcoholic fatty liver disease in the pediatric population: a review.

Wieckowska A, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Curr Opin Pediatr. 2005 Oct;17(5):636-41. doi: 10.1097/01.mop.0000172816.79637.c5. Curr Opin Pediatr. 2005. PMID: 16160540 Review.

4

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.

Carter-Kent C, Zein NN, Feldstein AE. Carter-Kent C, et al. Among authors: feldstein ae. Am J Gastroenterol. 2008 Apr;103(4):1036-42. doi: 10.1111/j.1572-0241.2007.01709.x. Epub 2008 Jan 2. Am J Gastroenterol. 2008. PMID: 18177455 Review.

5

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.

Wieckowska A, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Semin Liver Dis. 2008 Nov;28(4):386-95. doi: 10.1055/s-0028-1091983. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956295 Review.

6

Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.

Nobili V, Alkhouri N, Alisi A, Ottino S, Lopez R, Manco M, Feldstein AE. Nobili V, et al. Among authors: feldstein ae. Clin Gastroenterol Hepatol. 2009 May;7(5):575-9. doi: 10.1016/j.cgh.2008.12.031. Epub 2009 Jan 13. Clin Gastroenterol Hepatol. 2009. PMID: 19268270

7

Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease.

Alkhouri N, Lopez R, Berk M, Feldstein AE. Alkhouri N, et al. Among authors: feldstein ae. J Clin Gastroenterol. 2009 Nov-Dec;43(10):985-9. doi: 10.1097/MCG.0b013e3181a0998d. J Clin Gastroenterol. 2009. PMID: 19525859 Free PMC article.

8

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Alkhouri N, Dixon LJ, Feldstein AE. Alkhouri N, et al. Among authors: feldstein ae. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51. doi: 10.1586/egh.09.32. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19673631 Free PMC article. Review.

9

Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.

Lavine JE, Schwimmer JB, Molleston JP, Scheimann AO, Murray KF, Abrams SH, Rosenthal P, Sanyal AJ, Robuck PR, Brunt EM, Unalp A, Tonascia J; Nonalcoholic Steatohepatitis Clinical Research Network Research Group. Lavine JE, et al. Contemp Clin Trials. 2010 Jan;31(1):62-70. doi: 10.1016/j.cct.2009.09.001. Epub 2009 Sep 15. Contemp Clin Trials. 2010. PMID: 19761871 Free PMC article. Clinical Trial.

10

Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis.

Alkhouri N, Gornicka A, Berk MP, Thapaliya S, Dixon LJ, Kashyap S, Schauer PR, Feldstein AE. Alkhouri N, et al. Among authors: feldstein ae. J Biol Chem. 2010 Jan 29;285(5):3428-38. doi: 10.1074/jbc.M109.074252. Epub 2009 Nov 24. J Biol Chem. 2010. PMID: 19940134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page